ZNF599
gene geneOn this page
Also known as FLJ30663
Summary
ZNF599 (zinc finger protein 599, HGNC:26408) is a protein-coding gene on chromosome 19q13.11, encoding Zinc finger protein 599 (Q96NL3). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 148103 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 101 total
- MANE Select transcript:
NM_001007248
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26408 |
| Approved symbol | ZNF599 |
| Name | zinc finger protein 599 |
| Location | 19q13.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ30663 |
| Ensembl gene | ENSG00000153896 |
| Ensembl biotype | protein_coding |
| Entrez | 148103 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding, 2 nonsense_mediated_decay, 1 retained_intron
ENST00000329285, ENST00000587354, ENST00000588760, ENST00000588788, ENST00000673678, ENST00000673783
RefSeq mRNA: 1 — MANE Select: NM_001007248
NM_001007248
CCDS: CCDS32991
Canonical transcript exons
ENST00000329285 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001383883 | 34767316 | 34767411 |
| ENSE00001419749 | 34758073 | 34760559 |
| ENSE00002917037 | 34772824 | 34773215 |
| ENSE00003502965 | 34769429 | 34769555 |
Expression profiles
Bgee: expression breadth ubiquitous, 189 present calls, max score 87.87.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.8784 / max 37.9892, expressed in 1576 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180452 | 4.3700 | 1558 |
| 208777 | 0.5084 | 263 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 87.87 | gold quality |
| right uterine tube | UBERON:0001302 | 85.51 | gold quality |
| oviduct epithelium | UBERON:0004804 | 82.51 | gold quality |
| left testis | UBERON:0004533 | 81.66 | gold quality |
| right testis | UBERON:0004534 | 81.48 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 80.76 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 80.49 | gold quality |
| testis | UBERON:0000473 | 80.04 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 79.88 | gold quality |
| thyroid gland | UBERON:0002046 | 79.81 | gold quality |
| adenohypophysis | UBERON:0002196 | 79.81 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.17 | gold quality |
| pituitary gland | UBERON:0000007 | 78.80 | gold quality |
| body of uterus | UBERON:0009853 | 78.54 | gold quality |
| cortical plate | UBERON:0005343 | 78.10 | gold quality |
| endocervix | UBERON:0000458 | 77.99 | gold quality |
| metanephros cortex | UBERON:0010533 | 77.80 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.73 | gold quality |
| left ovary | UBERON:0002119 | 77.62 | gold quality |
| right ovary | UBERON:0002118 | 77.48 | gold quality |
| fallopian tube | UBERON:0003889 | 77.22 | gold quality |
| stromal cell of endometrium | CL:0002255 | 77.08 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 77.04 | gold quality |
| lower esophagus | UBERON:0013473 | 77.02 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 77.00 | gold quality |
| apex of heart | UBERON:0002098 | 76.94 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 76.92 | gold quality |
| right adrenal gland | UBERON:0001233 | 76.89 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 76.87 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 76.83 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.76 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
56 targeting ZNF599, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-6755-5P | 99.95 | 65.59 | 464 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-6744-5P | 99.93 | 66.82 | 748 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-4495 | 99.82 | 72.08 | 3080 |
| HSA-MIR-4755-5P | 99.71 | 70.34 | 2716 |
| HSA-MIR-5006-3P | 99.71 | 70.26 | 2728 |
| HSA-MIR-378A-5P | 99.65 | 66.33 | 1311 |
| HSA-MIR-3177-5P | 99.65 | 70.38 | 1174 |
| HSA-MIR-6727-3P | 99.49 | 65.92 | 1333 |
| HSA-MIR-143-3P | 99.49 | 69.05 | 1457 |
| HSA-MIR-4770 | 99.49 | 69.09 | 1451 |
| HSA-MIR-142-5P | 99.48 | 70.92 | 2416 |
| HSA-MIR-5590-3P | 99.48 | 70.91 | 2429 |
| HSA-MIR-6507-5P | 99.36 | 70.46 | 2524 |
| HSA-MIR-4284 | 99.36 | 65.25 | 1293 |
| HSA-MIR-4722-3P | 99.35 | 65.22 | 1099 |
| HSA-MIR-190B-3P | 99.33 | 68.29 | 1382 |
| HSA-MIR-888-5P | 99.30 | 70.15 | 1855 |
| HSA-MIR-6088 | 99.29 | 68.45 | 1284 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 599 — Q96NL3 (reviewed: Q96NL3)
All UniProt accessions (3): Q96NL3, A0A669KB57, K7EJP3
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96NL3-1 | 1 | yes |
| Q96NL3-2 | 2 |
RefSeq proteins (1): NP_001007249* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (20 total): zinc finger region 14, splice variant 2, chain 1, domain 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96NL3-F1 | 73.59 | 0.31 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 35 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN, BASAKI_YBX1_TARGETS_UP, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, DODD_NASOPHARYNGEAL_CARCINOMA_DN, CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN, KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES, KUMAR_AUTOPHAGY_NETWORK, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CEBPZ_TARGET_GENES, OVOL3_TARGET_GENES, ZNF350_TARGET_GENES, ZNF407_TARGET_GENES, MIR5688, MIR340_5P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
288 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF599 | SCGB2B2 | Q4G0G5 | 507 |
| ZNF599 | SPMIP7 | A4D263 | 407 |
| ZNF599 | RWDD4 | Q6NW29 | 405 |
| ZNF599 | TASOR2 | Q5VWN6 | 395 |
| ZNF599 | POGZ | Q7Z3K3 | 387 |
| ZNF599 | EFCAB13 | Q8IY85 | 383 |
| ZNF599 | ZBTB21 | Q9ULJ3 | 375 |
| ZNF599 | UBA2 | Q9UBT2 | 365 |
| ZNF599 | PHF8 | Q9UPP1 | 364 |
| ZNF599 | ZNF385B | Q569K4 | 355 |
| ZNF599 | TTK | P33981 | 352 |
| ZNF599 | LSM14A | Q8ND56 | 349 |
| ZNF599 | WTIP | A6NIX2 | 348 |
| ZNF599 | ZDHHC8 | Q9ULC8 | 326 |
| ZNF599 | MBOAT1 | Q6ZNC8 | 297 |
IntAct
129 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF599 | NDEL1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| NDEL1 | ZNF599 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF599 | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSGA10 | ZNF599 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CEP70 | ZNF599 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-9 | ZNF599 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF599 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZNF599 | ZRANB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLGA6L9 | ZNF599 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF599 | MAGI2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ZNF599 | DLG4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ZNF599 | DLG1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ZNF599 | DLG2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| MAGI3 | ZNF599 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ZNF599 | DLG3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ZNF599 | MAST2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ZNF599 | MAGI1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ZNF599 | GOPC | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ZNF599 | TJP2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ZNF599 | PDZD7 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ZNF599 | MAST1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
BioGRID (10): ZNF599 (Two-hybrid), ZNF599 (Two-hybrid), ZNF599 (Two-hybrid), ZNF599 (Two-hybrid), ZNF599 (Two-hybrid), ZNF599 (Two-hybrid), ZNF599 (Two-hybrid), NDEL1 (Two-hybrid), GOLGA6L9 (Two-hybrid), KRTAP10-9 (Two-hybrid)
ESM2 similar proteins: A0JNB1, A1YF12, A1YG88, A2T759, A3KN32, B2RUI1, O43296, O75123, P10072, P17020, P17097, P51814, P52736, P52740, Q07230, Q08ER8, Q13398, Q14590, Q32KN0, Q3KQV3, Q3MIS6, Q4V8A8, Q5CZA5, Q5RBQ3, Q5RBX0, Q5RCD9, Q5RCX4, Q6GQR8, Q6NX45, Q6P9A3, Q6PK81, Q7TSH9, Q7TSI0, Q7Z7L9, Q86UD4, Q8BFS8, Q8BLB0, Q8IVP9, Q8IZ26, Q8N9F8
Diamond homologs: A0A1W2PQL4, A0JNB1, A0JPL0, A6NK53, A6QLU5, A6QPT6, A7MBI1, A8MT65, A8MUV8, A8MWA4, B2RXC5, B4DU55, B4DX44, E9PYI1, O14628, O75346, P0CH99, P0CI00, P17014, P17030, P17032, P17098, P51786, P85977, Q02386, Q06730, Q06732, Q0VAW7, Q12901, Q13360, Q14586, Q14588, Q14590, Q16587, Q2M3X9, Q2VY69, Q32M78, Q3ZCX4, Q49AA0, Q4R6J4
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 81 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Ras activation upon Ca2+ influx through NMDA receptor | 5 | 51.0× | 2e-06 |
| Unblocking of NMDA receptors, glutamate binding and activation | 5 | 48.5× | 2e-06 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | 5 | 48.5× | 2e-06 |
| Assembly and cell surface presentation of NMDA receptors | 10 | 45.3× | 1e-12 |
| Dopamine Neurotransmitter Release Cycle | 5 | 44.3× | 2e-06 |
| Long-term potentiation | 5 | 42.5× | 3e-06 |
| Neurexins and neuroligins | 11 | 38.7× | 6e-13 |
| Protein-protein interactions at synapses | 7 | 33.2× | 1e-07 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| establishment or maintenance of epithelial cell apical/basal polarity | 10 | 76.5× | 2e-14 |
| protein localization to synapse | 6 | 60.5× | 9e-08 |
| receptor clustering | 7 | 57.5× | 6e-09 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 6 | 39.1× | 1e-06 |
| cell-cell adhesion | 9 | 12.0× | 4e-06 |
| protein-containing complex assembly | 8 | 12.0× | 2e-05 |
| chemical synaptic transmission | 7 | 7.1× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
101 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 91 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
598 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:34769423:TCTTA:T | donor_loss | 1.0000 |
| 19:34769424:CTTAC:C | donor_loss | 1.0000 |
| 19:34769425:TTAC:T | donor_loss | 1.0000 |
| 19:34769426:TACCC:T | donor_loss | 1.0000 |
| 19:34769427:AC:A | donor_gain | 1.0000 |
| 19:34769428:CC:C | donor_gain | 1.0000 |
| 19:34767411:CCTG:C | acceptor_gain | 0.9900 |
| 19:34769422:GTCTT:G | donor_loss | 0.9900 |
| 19:34769427:A:AC | donor_gain | 0.9900 |
| 19:34769428:C:CC | donor_gain | 0.9900 |
| 19:34769461:A:AC | donor_gain | 0.9900 |
| 19:34769467:T:TA | donor_gain | 0.9900 |
| 19:34769551:AATGC:A | acceptor_gain | 0.9900 |
| 19:34769553:TGC:T | acceptor_gain | 0.9900 |
| 19:34769556:C:CA | acceptor_loss | 0.9900 |
| 19:34769556:C:CC | acceptor_gain | 0.9900 |
| 19:34769557:T:C | acceptor_loss | 0.9900 |
| 19:34771317:A:AC | donor_gain | 0.9900 |
| 19:34772816:CCACT:C | donor_loss | 0.9900 |
| 19:34772817:CACTC:C | donor_loss | 0.9900 |
| 19:34772818:ACTCA:A | donor_loss | 0.9900 |
| 19:34772819:CTCA:C | donor_loss | 0.9900 |
| 19:34772820:TCAC:T | donor_loss | 0.9900 |
| 19:34772821:CA:C | donor_loss | 0.9900 |
| 19:34772823:C:A | donor_loss | 0.9900 |
| 19:34760573:A:T | acceptor_gain | 0.9800 |
| 19:34767311:CCAA:C | donor_loss | 0.9800 |
| 19:34767312:CAAC:C | donor_loss | 0.9800 |
| 19:34767313:AAC:A | donor_loss | 0.9800 |
| 19:34767314:ACC:A | donor_loss | 0.9800 |
AlphaMissense
3914 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:34759169:G:C | F544L | 0.997 |
| 19:34759169:G:T | F544L | 0.997 |
| 19:34759171:A:G | F544L | 0.997 |
| 19:34759253:A:C | F516L | 0.997 |
| 19:34759253:A:T | F516L | 0.997 |
| 19:34759255:A:G | F516L | 0.997 |
| 19:34759421:A:C | F460L | 0.997 |
| 19:34759421:A:T | F460L | 0.997 |
| 19:34759423:A:G | F460L | 0.997 |
| 19:34759589:A:C | F404L | 0.997 |
| 19:34759589:A:T | F404L | 0.997 |
| 19:34759591:A:G | F404L | 0.997 |
| 19:34759398:C:G | R468P | 0.996 |
| 19:34759505:A:C | F432L | 0.996 |
| 19:34759505:A:T | F432L | 0.996 |
| 19:34759507:A:G | F432L | 0.996 |
| 19:34759925:G:C | F292L | 0.996 |
| 19:34759925:G:T | F292L | 0.996 |
| 19:34759927:A:G | F292L | 0.996 |
| 19:34759230:C:G | R524P | 0.995 |
| 19:34759314:C:G | R496P | 0.995 |
| 19:34759566:C:G | R412P | 0.995 |
| 19:34759337:A:C | F488L | 0.994 |
| 19:34759337:A:T | F488L | 0.994 |
| 19:34759339:A:G | F488L | 0.994 |
| 19:34759478:A:C | H441Q | 0.993 |
| 19:34759478:A:T | H441Q | 0.993 |
| 19:34759142:G:C | H553Q | 0.992 |
| 19:34759142:G:T | H553Q | 0.992 |
| 19:34759310:G:C | H497Q | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000084033 (19:34788842 G>A,T), RS1000124083 (19:34784304 C>G,T), RS1000312005 (19:34795387 G>A), RS1000355057 (19:34774404 C>T), RS1000359046 (19:34795146 A>G), RS1000508215 (19:34770082 T>C,G), RS1000554140 (19:34793402 G>A), RS1000578688 (19:34768893 C>T), RS1000613845 (19:34761729 G>A), RS1000617571 (19:34775795 T>A), RS1000648350 (19:34762166 C>G), RS1000653035 (19:34807289 C>G,T), RS1000691300 (19:34776232 A>G), RS1000722248 (19:34808447 G>C,T), RS1000782873 (19:34775052 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002827_6 | Urate levels (BMI interaction) | 9.000000e-07 |
| GCST003427_56 | Alzheimer disease and age of onset | 4.000000e-07 |
| GCST006256_1 | Long-term memory (delayed word recall task) | 7.000000e-06 |
| GCST006993_14 | Hippocampal volume in Alzheimer’s disease dementia | 6.000000e-07 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0004531 | urate measurement |
| EFO:0004847 | age at onset |
| EFO:0006805 | word list delayed recall measurement |
| EFO:0005035 | hippocampal volume |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, decreases methylation, increases expression | 3 |
| Nickel | decreases expression | 2 |
| p-Chloromercuribenzoic Acid | affects cotreatment, decreases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| monomethylarsonous acid | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cannabidiol | decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.